Yahoo! Finance Search - Finance Home - Yahoo! - Help

Friday, October 31 2014 3:36pm ET - U.S. Markets close in 24 minutes.
Industry Center - Drug Delivery
Industry Center > Drug Delivery > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Delivery News
Latest News
Friday, Oct 31, 2014
·Aradigm (ARDM) Downgraded From Hold to Sell
at TheStreet.com - Fri 9:10 am ET
·Flamel Technologies Announces Third Quarter Results of Fiscal Year 2014
Marketwire - Fri 7:30 am ET
Thursday, Oct 30, 2014
·Molecular Profiles To Launch US Strategic Alliance At AAPS
PR Newswire - Thu 8:30 am ET
Wednesday, Oct 29, 2014
·DELCATH TO REPORT THIRD QUARTER 2014 RESULTS ON NOVEMBER 5, 2014
Thomson Reuters ONE - Wed 4:06 pm ET
·Alkermes reports 3Q loss
AP - Wed Oct 29
·InSite Vision to Report Third Quarter 2014 Financial Results on November 5, 2014
Business Wire - Wed Oct 29
·Alkermes plc Reports Third Quarter 2014 Financial Results
Business Wire - Wed Oct 29
Tuesday, Oct 28, 2014
·The Consequences of Saying No to a Hostile Takeover Bid
at The New York Times - Tue Oct 28
·Ackman-Allergan Enters Courtroom Phase: Opening Line
at Bloomberg - Tue Oct 28
·Acura Pharmaceuticals to Host Third Quarter 2014 Financial Results Conference Call on November 4, 2014
Marketwire - Tue Oct 28
·LEADING CANCER CENTERS TO PRESENT DATA FROM DELCATH'S CHEMOSAT/MELPHALAN HDS AT ESSO CONGRESS
Thomson Reuters ONE - Tue Oct 28
·Columbia Laboratories Reports Third Quarter 2014 Financial Results
PR Newswire - Tue Oct 28
·Ackman’s $5.3 Billion Allergan Bet Examined Before Vote
at Bloomberg - Tue Oct 28
Monday, Oct 27, 2014
·Takeover drama for your mama: Cramer reveals
at CNBC - Mon Oct 27
·Valeant Pharmaceuticals Eyes Raising Allergan Bid to $200 a Share
at TheStreet.com - Mon Oct 27
·Valeant Raises Allergan Takeover Bid
- Mon Oct 27
·Valeant: We'll bump Allergan offer to $200 a share
AP - Mon Oct 27
·Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons
PR Newswire - Mon Oct 27
·Valeant Ready to Raise Offer for Botox Maker Allergan
at The New York Times - Mon Oct 27
·Allergan (AGN) Stock Higher Today After Possible New Valeant Pharmaceuticals (VRX) Bid
at TheStreet.com - Mon Oct 27
More Latest News...
Sponsor Results
How To Avoid a Facelift
How To Tighten Loose, Sagging Skin Without Surgery, Lasers, or a Dr.
www.SkinCareSearch.com/FaceLifting
HRP-Based Antibody Arrays
HRP label-based antibody arrays. High sensitivity, many targets!
www.raybiotech.com
United Science QuEChERS
A Better Way to Recover your Planar Pesticides. No Toluene. No kidding.
uniscicorp.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Delivery Headlines
More Finance RSS Feeds


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?